SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)
KDUS 1.6000.0%Jul 2 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (726)2/19/2002 12:41:31 AM
From: BulbaMan  Read Replies (1) of 1833
 
The same reference with mention of Cadus was also made in last Saturday's NY Times.
nytimes.com
"Mr. Icahn is also the largest shareholder, with a 25 percent stake, in the Cadus Pharmaceutical (news/quote) Company, a New York drug discovery company that was spun off from ImClone in the early 1990's. In 1995, Mr. Icahn acquired ImClone's stake in Cadus for $6 million, saving ImClone from possible bankruptcy. Cadus still exists and its stock is traded, but the company has virtually ceased operations."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext